Serum levels of IL-18 in SLE patients after treatment (cyclophosphamide, methylprednisolone, prednisolone, mycophenolate mofetil, azathioprine) were related to poor clinical outcome, relating to SLEDAI score and severity of LN (69). The gene discussed is IL18; the disease is systemic lupus erythematosus.